Flamingo-01 Phase III GP2 Product Press Releases Email Alerts
Greenwich LifeSciences
  • ABOUT
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
  • TECHNOLOGY
    • OUR GLSI-100 CANCER IMMUNOTHERAPY PRODUCT
    • CANCER AND IMMUNOTHERAPY OVERVIEW
  • CLINICAL TRIALS
    • COMPLETED CLINICAL TRIALS
    • FLAMINGO-01 PHASE III CLINICAL TRIAL
  • INVESTORS & MEDIA
    • OVERVIEW
    • NEWS & EVENTS
    • COMPANY INFO
    • STOCK INFO
    • SEC FILINGS
    • GOVERNANCE
  • CONTACT
  • ABOUT
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
  • TECHNOLOGY
    • OUR GLSI-100 CANCER IMMUNOTHERAPY PRODUCT
    • CANCER AND IMMUNOTHERAPY OVERVIEW
  • CLINICAL TRIALS
    • COMPLETED CLINICAL TRIALS
    • FLAMINGO-01 PHASE III CLINICAL TRIAL
  • INVESTORS & MEDIA
    • OVERVIEW
    • NEWS & EVENTS
    • COMPANY INFO
    • STOCK INFO
    • SEC FILINGS
    • GOVERNANCE
  • CONTACT

Press Releases

Nasdaq: GLSI

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Presentations
    • FAQ
  • Stock Info
  • SEC Filings
  • Governance
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Dec 07, 2021 6:34am EST

Greenwich LifeSciences Expands Role of Industry Expert Dr. F. Joseph Daugherty to Include Medical Monitor for its Upcoming Phase III Clinical Trial

Dec 06, 2021 7:15am EST

Greenwich LifeSciences Announces Commencement of the First Commercial Line Filling of GP2

Nov 18, 2021 6:00am EST

Greenwich LifeSciences CEO Interview to Air on Bloomberg U.S. on the RedChip Money Report

Nov 17, 2021 6:00am EST

Greenwich LifeSciences to Participate in Jefferies’ 12th Annual London Healthcare Conference

Nov 11, 2021 6:00am EST

Greenwich LifeSciences Announces Acceptance of Two Posters at Upcoming 2021 SABCS Breast Cancer Conference

Nov 10, 2021 7:00am EST

Greenwich LifeSciences Provides Clinical Update on Upcoming Phase III Clinical Trial, FLAMINGO-01

Nov 09, 2021 6:00am EST

Greenwich LifeSciences Provides Updated Corporate Presentation and Webcasts

Sep 28, 2021 6:00am EDT

Greenwich LifeSciences to Partner with Susan G. Komen Race for the Cure Houston

Sep 27, 2021 6:00am EDT

Greenwich LifeSciences to Present at the Benzinga Healthcare Small Cap Conference

Sep 23, 2021 6:00am EDT

Greenwich LifeSciences to Present at the Cantor Global Healthcare Conference

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next
RSS

By proceeding to use this website, you consent to our use of cookies as described in our Privacy Policy.

Email Alerts

Sign up Now

Sign me up for:

  • Tear Sheet
  • RSS Feed
Logo of Greenwich LifeSciences.

Copyright © 2025

Greenwich LifeSciences, Inc.

ABOUT
TECHNOLOGY
CLINICAL TRIALS
INVESTORS & MEDIA
CONTACT
X logo
Privacy Policy
Disclaimer
Sitemap
Logo of Greenwich LifeSciences.

Copyright © 2025

Greenwich LifeSciences, Inc.

ABOUT
TECHNOLOGY
CLINICAL TRIALS
INVESTORS & MEDIA
CONTACT
Disclaimer
Privacy Policy
Sitemap
X logo